Skip to main content

Animations

MJFF Publications

2971 - 2980 of 6310 Results
Title
Year
  • Year
  • 2014
  • 2024
  • 2021
  • 2024
  • 2021
  • 2016
  • 2017
  • 2023
  • 2020
  • 2018
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1037/neu0000760
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Motor skill learning modulates striatal extracellular vesicles’ content in a mouse model of Huntington’s disease
    Journal Name: Cell Communication and Signaling
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12964-024-01693-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: HFE H63D Limits Nigral Vulnerability to Paraquat in Agricultural Workers
    Journal Name: Toxicological Sciences
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/toxsci/kfab020
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0153564
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Distinct alterations in Parkinson's medication-state and disease-state connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Machine learning nominates the inositol pathway and novel genes in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad345
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00139-6
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Immunosuppressants and risk of Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.580
    Citation Count: 79
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.